Molecular Oncology Lyskjær, I, Davies, C, Strobl, A C, Hindley, J, James, S, Lalam, R K, Cross, W, Hide, G, Rankin, K S, Jeys, L, Tirabosco, R, Stevenson, J, O’Donnell, P, Cool, P, Flanagan, A M & Genomics England Research Consortium 2021, ' Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations ', Molecular Oncology . https://doi.org/10.1002/1878-0261.13102 Molecular Oncology, Vol 15, Iss 12, Pp 3679-3690 (2021) Lyskjær, I 2021, ' Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations ', Molecular Oncology . https://doi.org/10.1002/1878-0261.13102
Lyskjær, I 2022, ' Osteosarcoma: Novel prognostic biomarkers using circulating and cell-free tumour DNA ', European Journal of Cancer, bind 168, nr. 1-11 . https://doi.org/10.1016/j.ejca.2022.03.002 Lyskjær, I, Kara, N, De Noon, S, Davies, C, Rocha, A M, Strobl, A C, Usher, I, Gerrand, C, Strauss, S J, Schrimpf, D, von Deimling, A, Beck, S & Flanagan, A M 2022, ' Osteosarcoma : Novel prognostic biomarkers using circulating and cell-free tumour DNA ', European Journal of Cancer, vol. 168, pp. 1-11 . https://doi.org/10.1016/j.ejca.2022.03.002